We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Randomized Placebo-controlled Trial Evaluating the Safety and Efficacy of Silymarin Treatment in Patients With Acute Viral Hepatitis

This study has been terminated.
(Low enrollment)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00755950
First Posted: September 19, 2008
Last Update Posted: June 9, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
MADAUS GmbH
The Egyptian Company for Blood Transfusion Services
Tanta Fever Hospital
Banha Fever Hospital
Alexandria University
Information provided by (Responsible Party):
Samer S. El-Kamary, University of Maryland
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2015
  Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)